{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:58:22Z","timestamp":1783475902339,"version":"3.55.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004337","name":"St George\u2019s University of London","doi-asserted-by":"publisher","award":["12729-58"],"award-info":[{"award-number":["12729-58"]}],"id":[{"id":"10.13039\/501100004337","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute for Health Research University College London Hospitals Biomedical Research Centre"},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG 08\/008"],"award-info":[{"award-number":["PG 08\/008"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Familial hypercholesterolaemia (FH) is an inherited disease of high LDL cholesterol (LDL-C) caused by defects in LDLR, APOB, APOE, and PCSK9 genes. A pathogenic variant cannot be found in \u223c60% of clinical FH patients. Using whole genome sequencing (WGS), we examined genetic determinants of FH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Whole genome sequencing data generated by the 100 000 Genomes Project (100KGP) included 536 FH patients diagnosed using the FH Simon\u2013Broome criteria. Rare variants in known FH genes were analysed. Genome-wide association study between 443 FH variant-negative unrelated FH cases and 77 275 control participants of the 100KGP was run using high-coverage WGS data. Polygenic risk scores for LDL-C (LDL PRS) and lipoprotein(a) (Lp(a) PRS) were computed. An FH-causing variant was found in 17.4% of FH cases. Genome-wide association study identified the LPA gene locus being significantly associated (P &amp;lt; 1 \u00d7 10\u22128). Familial hypercholesterolaemia variant-negative participants had higher LDL and Lp(a) PRSs in comparison with the controls (P &amp;lt; 1.0 \u00d7 10\u221216 and P &amp;lt; 4.09 \u00d7 10\u22126, respectively). Similar associations were found in the monogenic FH with both LDL and Lp(a) PRSs being higher than in controls (P &amp;lt; 4.03 \u00d7 10\u22124 and P &amp;lt; 3.01 \u00d7 10\u22123, respectively). High LDL PRS was observed in 36.4% of FH variant-negative cases, whereas high Lp(a) PRS in 18.5%, with 7.0% having both high LDL and Lp(a) PRSs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This genome-wide analysis of monogenic and polygenic FH causes confirms a complex and heterogeneous architecture of hypercholesterolaemia, with the LPA gene playing a significant role. Both Lp(a) and LDL-C should be measured for precision FH diagnosis. Specific therapies to lower Lp(a) should be targeted to those who will benefit most.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurjpc\/zwae371","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T15:30:10Z","timestamp":1731079810000},"page":"352-360","source":"Crossref","is-referenced-by-count":4,"title":["Variants in\n                    <i>LPA<\/i>\n                    are associated with familial hypercholesterolaemia: whole genome sequencing analysis in the 100 000 Genomes Project"],"prefix":"10.1093","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6837-6934","authenticated-orcid":false,"given":"Martin","family":"Bird","sequence":"first","affiliation":[{"name":"Experimental Cardiology, Cardiovascular and Genomics Research Institute, School of Health & Medical Sciences, City St George\u2019s, University of London , Cranmer Terrace, Tooting, SW17 0RE London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2971-4926","authenticated-orcid":false,"given":"Antoine","family":"Rimbert","sequence":"additional","affiliation":[{"name":"Nantes Universit\u00e9, CNRS, INSERM, l\u2019institut du thorax , F-44000 Nantes ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8112-2987","authenticated-orcid":false,"given":"Alan Michael","family":"Pittman","sequence":"additional","affiliation":[{"name":"Genomics, Cardiovascular and Genomics Research Institute, School of Health & Medical Sciences, City St George\u2019s, University of London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4153-8785","authenticated-orcid":false,"given":"Steve Eric","family":"Humphries","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Science, Faculty of Population Health, University College London , 5 University Street, WC1E 6JF London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2120-2088","authenticated-orcid":false,"given":"Marta","family":"Futema","sequence":"additional","affiliation":[{"name":"Experimental Cardiology, Cardiovascular and Genomics Research Institute, School of Health & Medical Sciences, City St George\u2019s, University of London , Cranmer Terrace, Tooting, SW17 0RE London ,","place":["UK"]},{"name":"Institute of Cardiovascular Science, Faculty of Population Health, University College London , 5 University Street, WC1E 6JF London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"key":"2026021723140899900_zwae371-B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(02)00330-1","article-title":"A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia","volume":"168","author":"Marks","year":"2003","journal-title":"Atherosclerosis"},{"key":"2026021723140899900_zwae371-B2","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/heartjnl-2015-308845","article-title":"Cardiovascular risk stratification in familial hypercholesterolaemia","volume":"102","author":"Sharifi","year":"2016","journal-title":"Heart"},{"key":"2026021723140899900_zwae371-B3","doi-asserted-by":"crossref","first-page":"e016461","DOI":"10.1136\/bmjopen-2017-016461","article-title":"Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis","volume":"7","author":"Akioyamen","year":"2017","journal-title":"BMJ Open"},{"key":"2026021723140899900_zwae371-B4","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1161\/ATVBAHA.123.319438","article-title":"Prevalence of FH-causing variants and impact on LDL-C concentration in European, South Asian, and African Ancestry roups of the UK Biobank-brief report","volume":"43","author":"Gratton","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026021723140899900_zwae371-B5","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia","volume":"67","author":"Khera","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026021723140899900_zwae371-B6","doi-asserted-by":"crossref","first-page":"a2423","DOI":"10.1136\/bmj.a2423","article-title":"Efficacy of statins in familial hypercholesterolaemia: a long term cohort study","volume":"337","author":"Versmissen","year":"2008","journal-title":"BMJ"},{"key":"2026021723140899900_zwae371-B7","doi-asserted-by":"crossref","first-page":"e000021","DOI":"10.1136\/bmjph-2023-000021","article-title":"Modelling a two-stage adult population screen for autosomal dominant familial hypercholesterolaemia: cross-sectional analysis within the UK Biobank","volume":"1","author":"Gratton","year":"2023","journal-title":"BMJ Public Health"},{"key":"2026021723140899900_zwae371-B8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/MOL.0000000000000173","article-title":"Improving the cost-effectiveness equation of cascade testing for familial hypercholesterolaemia","volume":"26","author":"Pears","year":"2015","journal-title":"Curr Opin Lipidol"},{"key":"2026021723140899900_zwae371-B9","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1399-0004.2009.01356.x","article-title":"Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade project","volume":"77","author":"Taylor","year":"2010","journal-title":"Clin Genet"},{"key":"2026021723140899900_zwae371-B10","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/eurjpc\/zwaa451","article-title":"Next-generation sequencing to confirm clinical familial hypercholesterolemia","volume":"28","author":"Reeskamp","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"2026021723140899900_zwae371-B11","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.athplu.2023.07.005","article-title":"How many FH genetic tests were performed by the UK genetic laboratory hubs in 2022?","volume":"54","author":"Humphries","year":"2023","journal-title":"Atheroscler Plus"},{"key":"2026021723140899900_zwae371-B12","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/jmedgenet-2014-102405","article-title":"Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR\/APOB\/PCSK9 mutations","volume":"51","author":"Futema","year":"2014","journal-title":"J Med Genet"},{"key":"2026021723140899900_zwae371-B13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCRESAHA.120.318141","article-title":"Posttranscriptional regulation of the human LDL receptor by the U2-spliceosome","volume":"130","author":"Zanoni","year":"2022","journal-title":"Circ Res"},{"key":"2026021723140899900_zwae371-B14","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-023-02211-z","article-title":"Genetic association analysis of 77,539 genomes reveals rare disease etiologies","volume":"29","author":"Greene","year":"2023","journal-title":"Nat Med"},{"key":"2026021723140899900_zwae371-B15","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/CIRCGEN.120.002919","article-title":"Polygenic contribution to low-density lipoprotein cholesterol levels and cardiovascular risk in monogenic familial hypercholesterolemia","volume":"13","author":"Trinder","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"2026021723140899900_zwae371-B16","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(12)62127-8","article-title":"Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study","volume":"381","author":"Talmud","year":"2013","journal-title":"Lancet"},{"key":"2026021723140899900_zwae371-B17","doi-asserted-by":"publisher","DOI":"10.1101\/2022.06.16.22276246","article-title":"UK Biobank release and systematic evaluation of optimised polygenic risk scores for 53 diseases and quantitative traits","author":"Thompson","year":"16  2022","journal-title":"medRxiv 22276246"},{"key":"2026021723140899900_zwae371-B18","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","article-title":"Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations","volume":"50","author":"Khera","year":"2018","journal-title":"Nat Genet"},{"key":"2026021723140899900_zwae371-B19","doi-asserted-by":"crossref","first-page":"e029223","DOI":"10.1161\/JAHA.122.029223","article-title":"Lipoprotein(a) genotype influences the clinical diagnosis of familial hypercholesterolemia","volume":"12","author":"Olmastroni","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2026021723140899900_zwae371-B20","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/eurheartj\/ehac660","article-title":"Lipoprotein(a) levels in children with suspected familial hypercholesterolaemia: a cross-sectional study","volume":"44","author":"de Boer","year":"2023","journal-title":"Eur Heart J"},{"key":"2026021723140899900_zwae371-B21","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jacc.2016.11.042","article-title":"A test in context: lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies","volume":"69","author":"Tsimikas","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026021723140899900_zwae371-B22","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1194\/jlr.R071233","article-title":"Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology","volume":"57","author":"Nordestgaard","year":"2016","journal-title":"J Lipid Res"},{"key":"2026021723140899900_zwae371-B23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2024.100757","article-title":"Genetically predicted lipoprotein(a) associates with coronary artery plaque severity independent of low-density lipoprotein cholesterol","author":"Clarke","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"2026021723140899900_zwae371-B24","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur Heart J"},{"key":"2026021723140899900_zwae371-B25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/330132a0","article-title":"cDNA sequence of human apolipoprotein(a) is homologous to plasminogen","volume":"330","author":"McLean","year":"1987","journal-title":"Nature"},{"key":"2026021723140899900_zwae371-B26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jamacardio.2020.5398","article-title":"Clinical utility of lipoprotein(a) and LPA genetic risk score in risk prediction of incident atherosclerotic cardiovascular disease","volume":"6","author":"Trinder","year":"2021","journal-title":"JAMA Cardiol"},{"key":"2026021723140899900_zwae371-B27","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/cge.14387","article-title":"Filling the gap: genetic risk assessment in hypercholesterolemia using LDL-C and LPA genetic scores","volume":"104","author":"Schwaninger","year":"2023","journal-title":"Clin Genet"},{"key":"2026021723140899900_zwae371-B28","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1056\/NEJMoa2035790","article-title":"100,000 genomes pilot on rare-disease diagnosis in health care\u2014preliminary report","volume":"385","author":"100,000 Genomes Project Pilot Investigators","year":"2021","journal-title":"N Engl J Med"},{"key":"2026021723140899900_zwae371-B29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"2026021723140899900_zwae371-B30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.gim.2021.09.012","article-title":"The Clinical Genome Resource (ClinGen) familial hypercholesterolemia variant curation expert panel consensus guidelines for LDLR variant classification","volume":"24","author":"Chora","year":"2022","journal-title":"Genet Med"},{"key":"2026021723140899900_zwae371-B31","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1126\/science.290.5497.1771","article-title":"Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters","volume":"290","author":"Berge","year":"2000","journal-title":"Science"},{"key":"2026021723140899900_zwae371-B32","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/cvr\/cvab136","article-title":"Cis-epistasis at the LPA locus and risk of cardiovascular diseases","volume":"118","author":"Zeng","year":"2022","journal-title":"Cardiovasc Res"},{"key":"2026021723140899900_zwae371-B33","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/ng.3396","article-title":"A comprehensive 1000 Genomes\u2013based genome-wide association meta-analysis of coronary artery disease","volume":"47","author":"Nikpay","year":"2015","journal-title":"Nat Genet"},{"key":"2026021723140899900_zwae371-B34","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1194\/jlr.M076232","article-title":"A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms","volume":"58","author":"Mack","year":"2017","journal-title":"J Lipid Res"},{"key":"2026021723140899900_zwae371-B35","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41586-021-04064-3","article-title":"The power of genetic diversity in genome-wide association studies of lipids","volume":"600","author":"Graham","year":"2021","journal-title":"Nature"},{"key":"2026021723140899900_zwae371-B36","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.118.034311","article-title":"Lipoprotein(a) levels and the risk of myocardial infarction among 7 ethnic groups","volume":"139","author":"Par\u00e9","year":"2019","journal-title":"Circulation"},{"key":"2026021723140899900_zwae371-B37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/humu.22215","article-title":"Description of a large family with autosomal dominant hypercholesterolemia associated with the APOE p.Leu167del mutation","volume":"34","author":"Marduel","year":"2013","journal-title":"Hum Mutat"},{"key":"2026021723140899900_zwae371-B38","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S2213-8587(16)30042-0","article-title":"High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study","volume":"4","author":"Langsted","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026021723140899900_zwae371-B39","article-title":"Extension of heterozygous familial hypercholesterolemia treatment recommendations by including both low-density lipoprotein and lipoprotein(a) burden\u2014a unique opportunity to improve patient prognosis","author":"Vuorio","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"2026021723140899900_zwae371-B40","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s40265-024-02046-z","article-title":"Therapeutic potential of lipoprotein(a) inhibitors","volume":"84","author":"Nicholls","year":"2024","journal-title":"Drugs"},{"key":"2026021723140899900_zwae371-B41","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1038\/s41467-020-17374-3","article-title":"Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions","volume":"11","author":"Fahed","year":"2020","journal-title":"Nat Commun"},{"key":"2026021723140899900_zwae371-B42","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1161\/ATVBAHA.123.320287","article-title":"Influence of polygenic background on the clinical presentation of familial hypercholesterolemia","volume":"44","author":"Trinder","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026021723140899900_zwae371-B43","doi-asserted-by":"crossref","first-page":"100662","DOI":"10.1016\/j.jacadv.2023.100662","article-title":"Polygenic background modifies risk of coronary artery disease among individuals with heterozygous familial hypercholesterolemia","volume":"2","author":"Reeskamp","year":"2023","journal-title":"JACC Adv"},{"key":"2026021723140899900_zwae371-B44","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1073\/pnas.71.3.788","article-title":"Familial hypercholesterolemia: defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity","volume":"71","author":"Brown","year":"1974","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwae371\/60967931\/zwae371.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/33\/3\/352\/60967931\/zwae371.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/33\/3\/352\/60967931\/zwae371.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T04:14:16Z","timestamp":1771388056000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/article\/33\/3\/352\/7896311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,12]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,11,12]]},"published-print":{"date-parts":[[2026,2,18]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwae371","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2024,11,12]]}}}